ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

May 31, 2025

Study Completion Date

May 31, 2025

Conditions
Knee SurgeryPelvic SurgerySpinal Aneshtesia
Interventions
DRUG

Dexmedetomidine 3 mcg

Patient received spinal injection of dexmedetomidine 3 mcg.

DRUG

Dexmedetomidine 4 mcg

Patient received spinal injection of dexmedetomidine 4 mcg.

DRUG

Dexmedetomidine 5 mcg

Patient received spinal injection of dexmedetomidine 5 mcg.

DRUG

Dexmedetomidine 6 mcg

Patient received spinal injection of dexmedetomidine 6 mcg.

DRUG

Bupivacain hyperbaric 0.5% 12.5 mg

Patient received spinal injection of Bupivacain hyperbaric 0.5% 12.5 mg

Trial Locations (1)

10430

RSUPN Cipto Mangunkusumo, Jakarta Pusat

All Listed Sponsors
lead

Indonesia University

OTHER

NCT07144215 - ED50 of Dexmedetomidine as an Adjuvant to 0.5% Hyperbaric Bupivacaine 12.5 mg for Spinal Anesthesia in Hip and Knee Surgery: An Up-and-Down Method Approach | Biotech Hunter | Biotech Hunter